Cargando...
Immunotherapy of hepatocellular carcinoma using chimeric antigen receptors and bispecific antibodies
Hepatocellular carcinoma (HCC) is one of the most lethal cancers worldwide with an overall survival rate of less than 15% in developed countries. Despite attempts at new therapeutic strategies, the majority of patients succumb to this cancer. Buttressed by the highly successful clinical impact in me...
Guardado en:
| Publicado en: | Cancer Lett |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5496242/ https://ncbi.nlm.nih.gov/pubmed/28428075 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2017.04.013 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|